David A. Horwitz
12Patents
7h-index
7Co-inventors
55Inventor score
Filing activity: Nov 5, 1998 → Apr 21, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7824333B2 | Diabetes management methods and systems | Physics | 52 | Active |
| US6447765B1 | Use of cytokines and mitogens to inhibit graft versus host disease | Emerging Cross-Sectional Technologies | 41 | Expired |
| US6803036B1 | Use of cytokines, cells and mitogens to inhibit graft versus host disease | Chemistry; Metallurgy | 15 | Expired |
| US6759035B2 | Method to prevent graft rejection using TGF-beta to induce T suppressor cells | Chemistry; Metallurgy | 12 | Expired |
| US6797267B2 | Use of cytokines and mitogens to inhibit pathological immune responses | Chemistry; Metallurgy | 9 | Expired |
| US6228359A | Use of cytokines and mitogens to inhibit pathological immune responses | Chemistry; Metallurgy | 8 | Expired |
| US6358506B1 | Use of cytokines and mitogens to inhibit pathological immune responses | Chemistry; Metallurgy | 7 | Expired |
| US8951796B2 | Methods and compositions for expanding and stabilizing natural regulatory T cells | Chemistry; Metallurgy | 1 | Active |
| US7115259B2 | Use of cytokines and mitogens to inhibit pathological immune responses | Chemistry; Metallurgy | 1 | Expired |
| US7799350B2 | Use of cytokines and mitogens to inhibit graft versus host disease | Emerging Cross-Sectional Technologies | 0 | Active |
| US8439837B2 | Systems and methods for detecting hypoglycemic events having a reduced incidence of false alarms | Human Necessities | 0 | Active |
| US7381563B2 | Use of cytokines and mitogens to inhibit graft versus host disease | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.